Medications Updated During 2018, From Newest to Oldest, Page 10

Page 10 of 772 « First Page « … 5 … 8 9 10 11 12 … 15 20 25 30 35 … » Last Page »

Carisoprodol

Limitation of Use. Carisoprodol tablets are indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults. Carisoprodol tablets should only be…

Actavis Pharma, Inc.28 December 2018

Escitalopram

Escitalopram is a selective serotonin reuptake inhibitor (SSRI) indicated for: Acute and Maintenance Treatment of Major Depressive Disorder (MDD) in adults and adolescents aged 12-17…

SOLCO HEALTHCARE US, LLC28 December 2018

SILDENAFIL

Sildenafil tablets are indicated for the treatment of erectile dysfunction. 2.1 Dosage Information For most patients, the recommended dose is 50 mg taken, as needed, approximately 1 hour…

H.J. Harkins Company, Inc.28 December 2018

Metformin

Metformin hydrochloride extended-release tablets are a biguanide indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. (1)…

Ingenus Pharmaceuticals, LLC28 December 2018

GLUCOVANCE (GLYBURIDE AND METFORMIN HYDROCHLORIDE)

GLUCOVANCE is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. GLUCOVANCE is a combination of glyburide, a sulfonylurea,…

Bristol-Myers Squibb Company28 December 2018

Page 10 of 772 « First Page « … 5 … 8 9 10 11 12 … 15 20 25 30 35 … » Last Page »

FDA Medwatch

CME America Announces a Follow-Up on the Voluntary Recall of BodyGuard® Infusion System Administration Sets
Tue, 07 Jul 2020. As part of CME America's commitment to quality, following the previously announced recall (April 27, 2020) of the BodyGuard® Infusion Pump Systems, the company conducted additional flow-rate accuracy testing. This testing revealed that some…
Lupin Pharmaceuticals, Inc. Issues Voluntarily Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, 500mg and 1000mg Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity
Tue, 07 Jul 2020. Lupin Pharmaceuticals Inc. is voluntarily recalling all batches of Metformin Hydrochloride Extended-Release Tablets USP, 500mg and 1000mg to the consumer level. As part of the ongoing assessment and continuation of the dialog with the FDA,…

MedLibrary.org

Medication Sections

RSS Feeds

About

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.